China approves sales of first domestically developed 13-valent pneumonia vaccine

China has approved a pneumonia vaccine developed by domestic drugmaker Walvax Biotechnology, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to Pfizer's market-dominating Prevnar 13.


from Reuters: Health News https://ift.tt/37iPIlA

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home